0001752724-20-205280.txt : 20201013
0001752724-20-205280.hdr.sgml : 20201013
20201013090241
ACCESSION NUMBER: 0001752724-20-205280
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200731
FILED AS OF DATE: 20201013
DATE AS OF CHANGE: 20201013
EFFECTIVENESS DATE: 20201013
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AB CAP FUND, INC.
CENTRAL INDEX KEY: 0000081443
IRS NUMBER: 132625045
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-01716
FILM NUMBER: 201234850
BUSINESS ADDRESS:
STREET 1: ALLIANCEBERNSTEIN LP
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
BUSINESS PHONE: 2129691000
MAIL ADDRESS:
STREET 1: ALLIANCEBERNSTEIN LP
STREET 2: 1345 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10105
FORMER COMPANY:
FORMER CONFORMED NAME: ALLIANCEBERNSTEIN CAP FUND, INC.
DATE OF NAME CHANGE: 20110524
FORMER COMPANY:
FORMER CONFORMED NAME: ALLIANCEBERNSTEIN CAP FUND,INC
DATE OF NAME CHANGE: 20040908
FORMER COMPANY:
FORMER CONFORMED NAME: ALLIANCEBERNSTEIN SMALL CAP GROWTH FUND INC
DATE OF NAME CHANGE: 19931001
0000081443
S000010309
AB Small Cap Growth Portfolio
C000028521
Class A
QUASX
C000028522
Class B
QUABX
C000028523
Class C
QUACX
C000028524
Advisor Class
QUAYX
C000028525
Class R
QUARX
C000028526
Class K
QUAKX
C000028527
Class I
QUAIX
C000159958
Class Z
QUAZX
N-CEN
1
primary_doc.xml
X0303
N-CEN
LIVE
0000081443
XXXXXXXX
811-01716
false
false
false
N-1A
S000010309
C000028523
C000028527
C000028524
C000159958
C000028522
C000028521
C000028526
C000028525
AB CAP FUND, INC.
811-01716
0000081443
549300I24E20QB4B6Y20
ALLIANCEBERNSTEIN LP
1345 AVENUE OF THE AMERICAS
NEW YORK
10105
US-NY
US
212-969-1000
State Street Bank and Trust Company
1 Lincoln Street
Boston
02111
617-786-3000
Custody and Accounting Records
Brown Brothers Harriman & Co.
50 Post Office Square
Boston
02110
617-772-1818
Custody and Accounting Records
N
N
N-1A
15
Y
Carol C. McMullen
000000000
N
Michael J. Downey
000000000
N
Garry L. Moody
000000000
N
Robert M. Keith
002309907
Y
Jorge A. Bermudez
000000000
N
Nancy P. Jacklin
000000000
N
Earl D. Weiner
000000000
N
Jeanette Loeb
000000000
N
Marshall C. Turner, Jr.
000000000
N
Vincent S. Noto
000000000
1345 Avenue of the Americas
New York
10105
XXXXXX
N
N
N
N
N
N
AllianceBernstein Investments, Inc.
8-30851
000014549
0000000000
Y
N
Ernst & Young LLP
42
00000000000000000000
N
N
N
N
N
N
AB Small Cap Growth Portfolio
S000010309
549300DUMEQYBRQHJC25
N
9
0
0
N/A
N
N
Y
N
N
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Revenue sharing split
540731251.37000000
3438283.00000000
Rule 32a-4 (17 CFR 270.32a-4)
Rule 12d1-1 (17 CFR 270.12d1-1)
Rule 22d-1 (17 CFR 270.22d-1)
Rule 17e-1 (17 CFR 270.17e-1)
Y
Y
N
N
AllianceBernstein L.P.
801-56720
000108477
0JK55UGWSWNF3X7KLQ85
N
AllianceBernstein Investor Services, Inc.
084-01187
0000000000
Y
N
N
Bloomberg L.P.
549300B56MD0ZC402L06
N
Standard & Poor's Financial Services LLC
549300U4VWNITEKO2881
N
PricingDirect Inc.
549300WIC0TOJ7N7GD54
N
ICE Data Services, Inc.
13-3668779
Tax ID
N
Refinitiv US Holdings Inc.
549300NF240HXJO7N016
N
IHS Markit Ltd.
549300HLPTRASHS0E726
GB
N
Vertical Management Systems, Inc.
27-3275288
Tax ID
N
N
State Street Bank and Trust Company
571474TGEMMWANRLN572
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
State Street Bank and Trust Company (Edinburgh, GB, Branch)
571474TGEMMWANRLN572
GB
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
UBS Switzerland AG
549300WOIFUSNYH0FL22
CH
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
AllianceBernstein Investor Services, Inc.
0000000000
Y
N
N
AllianceBernstein L.P.
0JK55UGWSWNF3X7KLQ85
Y
N
N
Sanford C. Bernstein Limited
N/A
000000000
54930049G8WQ5OOUSD19
GB
0.00000000
Sanford C. Bernstein & Co., LLC
8-52942
000104474
549300I7JYZHT7D5CO04
0.20000000
Citation Group Ltd.
8-43632
000028305
00000000000000000000
76602.50000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
112786.72000000
Goldman Sachs & Co. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
283502.69000000
Credit Suisse Securities (USA) LLC
8-422
000000816
1V8Y6QCX6YMJ2OELII46
88616.91000000
Liquidnet, Inc.
8-52461
000103987
213800HSKBBO1GCVRG79
54319.66000000
UBS Securities LLC
8-22651
000007654
T6FIZBDPKLYJKFCRVK44
73924.67000000
Barclays Capital Inc.
8-41342
000019714
AC28XWWI3WIBK2824319
59166.61000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
108887.82000000
Citigroup Global Markets Inc.
8-8177
000007059
MBNUM2BPBDO7JBLYG310
23981.39000000
Cowen and Company, LLC
8-22522
000007616
549300WR155U7DVMIW58
94973.66000000
1115820.65000000
Barclays Capital Inc.
8-41342
000019714
AC28XWWI3WIBK2824319
15699567.00000000
RBC Capital Markets, LLC
8-45411
000031194
549300LCO2FLSSVFFR64
15627005.00000000
Credit Suisse Securities (USA) LLC
8-422
000000816
1V8Y6QCX6YMJ2OELII46
18762266.25000000
Goldman Sachs & Co. LLC
8-129
000000361
FOR8UP27PHTHYVLBNG30
44617494.50000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
48787257.50000000
SVB Leerink LLC
8-48535
000039011
549300AAH7U76CEUBI94
5878716.00000000
National Financial Services LLC
8-26740
000013041
549300JRHF1MHHWUAW04
7289249.50000000
Bofa Securities, Inc.
8-69787
000283942
549300HN4UKV1E2R3U73
66988726.75000000
State Street Bank and Trust Company
N/A
000000000
571474TGEMMWANRLN572
1595870766.38000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
85084614.40000000
1905778163.28000000
Y
2337423326.78000000
Committed
325000000.00000000
N
N
N
N
true
INTERNAL CONTROL RPT
2
NCEN_2184903325283808.txt
Report of Independent Registered Public
Accounting Firm
To the Shareholders and Board of Directors of AB
Small Cap Growth Portfolio:
In planning and performing our audit of the
financial statements of AB Small Cap Growth
Portfolio, (the "Fund"), one of the portfolios
constituting the AB Cap Fund, Inc., as of and for
the year ended July 31, 2020, in accordance with
the standards of the Public Company Accounting
Oversight Board (United States), we considered the
Fund's internal control over financial reporting,
including controls over safeguarding securities, as a
basis for designing our auditing procedures for the
purpose of expressing our opinion on the financial
statements and to comply with the requirements of
Form N-CEN, but not for the purpose of expressing
an opinion on the effectiveness of the Fund's
internal control over financial reporting.
Accordingly, we express no such opinion.
The management of the Fund is responsible for
establishing and maintaining effective internal
control over financial reporting. In fulfilling this
responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls. A company's
internal control over financial reporting is a process
designed to provide reasonable assurance regarding
the reliability of financial reporting and the
preparation of financial statements for external
purposes in accordance with U.S. generally
accepted accounting principles. A company's
internal control over financial reporting includes
those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2)
provide reasonable assurance that transactions are
recorded as necessary to permit preparation of
financial statements in accordance with U.S.
generally accepted accounting principles, and that
receipts and expenditures of the company are being
made only in accordance with authorizations of
management and directors of the company; and (3)
provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use
or disposition of a company's assets that could have
a material effect on the financial statements.
Because of its inherent limitations, internal control
over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the
risk that controls may become inadequate because
of changes in conditions, or that the degree of
compliance with the policies or procedures may
deteriorate.
A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees,
in the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis. A material weakness is a deficiency, or
a combination of deficiencies, in internal control
over financial reporting, such that there is a
reasonable possibility that a material misstatement
of the company's annual or interim financial
statements will not be prevented or detected on a
timely basis.
Our consideration of the Fund's internal control
over financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control that might be material weaknesses under
standards established by the Public Company
Accounting Oversight Board (United States).
However, we noted no deficiencies in the Fund's
internal control over financial reporting and its
operation, including controls over safeguarding
securities that we consider to be a material
weakness as defined above as of July 31, 2020.
This report is intended solely for the information
and use of management and the Board of Directors
of AB Small Cap Growth Portfolio and the
Securities and Exchange Commission, and is not
intended to be and should not be used by anyone
other than these specified parties.
/s/ ERNST & YOUNG LLP
New York, New York
September 25, 2020